Proteomics
Pioneering Proteomics in Rheumatic Disease Research
In recent years, advances in proteomics and the analysis of large patient cohorts have improved the understanding of rheumatic diseases such as osteoarthritis and rheumatoid arthritis (RA). Our research has not only confirmed the presence of inflammation-related proteins such as S100 and SAA in the early 2000s1,2, but has also uncovered new biomarkers that could change the way these diseases are diagnosed and monitored.
Innovative Biomarker Discovery in Osteoarthritis
Our team has identified specific peptides, including the complement factor C3f and a fragment of vitronectin, that are present in osteoarthritis3. Using nano-liquid chromatography on chip tandem mass spectrometry, we have developed a novel approach for the absolute quantification of these peptides4. This method allowed us to accurately measure the vitronectin fragment VTN(381-397 a.a.) in serum samples of various rheumatic diseases5. Its biological role was also investigated (see section related to “fibrosis”).
Glycoprotein Research in Rheumatoid Arthritis
Our proteomic research has also focused on the glycosylation status of glycoproteins in the early stages of rheumatoid arthritis. We found that the glycosylation of key proteins such as corticosteroid-binding globulin (CBG) and lipopolysaccharide-binding protein (LBP) is altered in RA. Remarkably, these changes can be reversed after one year of treatment6. This finding highlights the potential of glycoproteins as valuable biomarkers both for diagnosing RA and for monitoring treatment response.
Proteins associated with inflammation and ER stress in rheumatic diseases
We also used mass spectrometry (2D-nano-UPLC-ESI-Q-Orbitrap) to identify proteins involved in endoplasmic reticulum (ER) stress, inflammation and pannus formation in synovial biopsies from patients with osteoarthritis, chronic pyrophosphate arthropathy and rheumatoid arthritis7,8. These proteins were detected in all samples and showed a strong correlation with histological inflammatory scores, highlighting their critical role in synovial inflammation and immune cell infiltration.
Transforming diagnostics and treatment monitoring
Our ongoing research in proteomics is uncovering new biomarkers and providing deeper insights into the molecular mechanisms of rheumatic diseases. These discoveries not only improve our ability to diagnose OA and RA earlier, but also offer new ways to monitor treatment response, ultimately leading to more personalized and effective therapies.
References
de Seny D, Fillet M, Meuwis MA, Geurts P, Lutteri L, Ribbens C, Bours V, Wehenkel L, Piette J, Malaise M and Merville MP.
Arthritis Rheum. 2005, 52, 3801-3812.
Monomeric calgranulins measured by SELDI-TOF mass spectrometry and calprotectin measured by ELISA as biomarkers in arthritis
de Seny D, Fillet M, Ribbens C, Maree R, Meuwis MA, Lutteri, L, Chapelle JP, Wehenkel L, Louis E, Merville MP and Malaise M.
Clin Chem. 2008, 54, 1066-1075.
Discovery and biochemical characterisation of four novel biomarkers for osteoarthritis
de Seny D, Sharif M, Fillet M, Cobraiville G, Meuwis MA, Maree R, Hauzeur JP, Wehenkel L, Louis E, Merville MP, Kirwan J, Ribbens C, and Malaise M.
Ann Rheum Dis. 2011, 70, 1144-1152.
Cobraiville G, Fillet M, Sharif M, Ourradi K, Nys G, Malaise MG, de Seny D.
Talanta. 2017, 169:170-180.
Modulation of αVβ6 integrin in osteoarthritis synovitis and interaction with VTN(381-397 a.a.) competing for TGF-β1 activation
Ciregia F, Deroyer C, Cobraiville G, Plener Z, Malaise O, Gillet P, Fillet M, Malaise MG, de Seny D.
Experimental & Molecular Medicine. 2021 53:210-222.
Ciregia F, Baiwir D, Cobraiville G, Dewael T, Mazzucchelli G, Badot V, Di Romana S, Sidiras P, Sokolova T, Durez P, Malaise MG, de Seny D.
J Transl Med. 2020, 18:8.
de Seny D, Bianchi E, Baiwir D, Cobraiville G, Collin C, Deliège M, Kaiser MJ, Mazzucchelli G, Hauzeur JP, Delvenne P, Malaise MG.
Sci Rep. 2020, 10:14159.
de Seny D, Baiwir D, Bianchi E, Cobraiville G, Deroyer C, Poulet C, Malaise O, Paulissen G, Kaiser MJ, Hauzeur JP, Mazzucchelli G, Delvenne P, Malaise M.
Int J Mol Sci. 2021, 23:434.
